Cure Therapeutics is an early-stage pharmaceutical company dedicated to the development and commercialization of an important new class of nitric oxide-based drugs used to treat musculoskeletal disease. Cure Therapeutic’s principal intellectual property was licensed from the Hospital for Special Surgery, New York.

To learn more about this company:

www.curetherapeutics.com